Impact of previous macrolide use on invasive pneumococcal disease due to erythromycin-resistant serotypes in adults over 59 years of age.

Autor: Chávez ACF; Preventive Medicine and Public Health, Hospital Universitario Ramón y Cajal, IRYCIS, Ctra. de Colmenar Viejo km. 9100, 28034, Madrid, Spain. abelardoclaudio.fernandez@salud.madrid.org., Comas LG; Epidemiology Service of Health Department of the Community of Madrid, Madrid, Spain., Espinosa LM; Internal Medicine Service, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain., Lobo JY; Pneumococcal Unit, National Centre for Microbiology, Instituto de Salud Carlos III and CIBER of Respiratory Diseases (CIBERES), Madrid, Spain., de Provens OCP; Faculty of Health of UNIR, Madrid, Spain., Andrés JMA; Preventive Medicine and Public Health, Hospital Universitario Ramón y Cajal, IRYCIS, CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Publikováno v: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2022 Feb; Vol. 41 (2), pp. 227-234. Date of Electronic Publication: 2021 Oct 31.